Traditional Cardiovascular Risk Factors and Coronary Artery Calcification in Adults With Polymyositis and Dermatomyositis: A Danish Multicenter Study

To determine the occurrence of traditional cardiovascular (CV) risk factors and coronary artery calcification (CAC) in adults with polymyositis (PM) or dermatomyositis (DM) compared to healthy controls and to assess the association between CV risk factors, PM/DM, and CAC score.

[1]  S. Shinjo,et al.  Analysis of Metabolic Syndrome in Adult Dermatomyositis With a Focus on Cardiovascular Disease , 2013, Arthritis care & research.

[2]  H. Wang,et al.  Lipid profiles in untreated patients with dermatomyositis , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Stowasser,et al.  Adverse cardiovascular outcomes of corticosteroid excess. , 2012, Endocrinology.

[4]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[5]  J. Knight,et al.  Physical inactivity: associated diseases and disorders. , 2012, Annals of clinical and laboratory science.

[6]  P. Høilund-Carlsen,et al.  Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study , 2012, European journal of preventive cardiology.

[7]  O. Gerke,et al.  The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy , 2012, Journal of internal medicine.

[8]  P. Khong,et al.  Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. , 2012, Clinical and experimental rheumatology.

[9]  R. Woodman,et al.  Mortality and its predominant causes in a large cohort of patients with biopsy‐determined inflammatory myositis , 2012, Internal medicine journal.

[10]  L. Thygesen,et al.  Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving , 2011, Scandinavian journal of public health.

[11]  D. Isenberg,et al.  Interrater reliability and aspects of validity of the myositis damage index , 2011, Annals of the rheumatic diseases.

[12]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[13]  A. Mammen,et al.  A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. , 2010, Arthritis and rheumatism.

[14]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[15]  V. Limaye,et al.  Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus , 2010, International journal of rheumatic diseases.

[16]  M. Weisman,et al.  Low physical activity is associated with proinflammatory high‐density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus , 2010, Arthritis care & research.

[17]  C. Pineau,et al.  Arterial Events in Persons with Dermatomyositis and Polymyositis , 2009, The Journal of Rheumatology.

[18]  A. Nevill,et al.  Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[19]  D. Isenberg,et al.  Reliability and validity of the myositis disease activity assessment tool. , 2008, Arthritis and rheumatism.

[20]  R. Kronmal,et al.  Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) , 2008, European heart journal.

[21]  P. Libby.  Role of inflammation in atherosclerosis associated with rheumatoid arthritis. , 2008, The American journal of medicine.

[22]  L. Kuller,et al.  C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. , 2008, The American journal of cardiology.

[23]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[24]  H. Kautiainen,et al.  Prognosis and mortality of polymyositis and dermatomyositis patients , 2006, Clinical Rheumatology.

[25]  Tebeb Gebretsadik,et al.  Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. , 2005, Arthritis and rheumatism.

[26]  G. Borgulya,et al.  Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features: A Longitudinal Study of 162 Cases , 2004, Medicine.

[27]  Paolo Raggi,et al.  Premature coronary-artery atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.

[28]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[29]  T. Vischer,et al.  Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. , 1994, Arthritis and rheumatism.

[30]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[31]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[32]  K. Liao,et al.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. , 2013, Rheumatology.

[33]  G. Serratrice,et al.  International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. , 2004, Rheumatology.

[34]  D. Isenberg,et al.  Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. , 2002, Rheumatology.

[35]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.